Pharma Articles

Articles on key issues related to the pharma industry from the heads of leading pharmaceutical companies and pharma industry experts across the globe. The pharma industry articles' section focuses on current and emerging issues in areas such as Strategic developments in the pharma industry, pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical manufacturing, biopharmaceuticals, and information technology.

Nanotechnology as a Potential Therapeutic Strategy in Breast Cancer Management

Breast cancer BrCr is the most commonly diagnosed cancer among women and continues to be a major global health burden Despite significant progress in early detection and conventional treatments such as surgery chemotherapy radiotherapy and hormone therapy breast cancer remains associated with high r...

Probiotics as live Biomolecules to Manage Sleep Disorders

Insomnia is a widespread sleep disorder characterised by difficulty falling or staying asleep or experiencing nonrestorative sleep that occurs frequently Although sleep is essential for maintaining good health and wellbeing sleep disorders are becoming increasingly prevalent Probiotics may play a ro...

Tiny Vesicles, Big Impact

Unlocking Exosomes in cancer chemotherapy

Exosomes have emerged as a promising area of research with significant potential in drug delivery and diagnosis in cancer These tiny particles previously regarded as cellular waste are now acknowledged for their crucial function in intercellular communication and their ability to transport molecular...

Unleashing the Power of Data, Collaboration, and Innovation in Drug Development

IntroductionDrug discovery and development is one of the most dataintensive enterprises in modern science Vast amounts of information are generated at every stagegenomic datasets highthroughput screening results clinical trial outcomes regulatory submissions realworld evidence and patientreported da...

Reshaping the Clinical Trial Model

A Call for Integration, Innovation, and Data-Driven Design

If we were to reimagine how we conduct clinical trials today would we use the same methods weve relied on for decades I would argueabsolutely not The traditional model while foundational is no longer fit for purpose in a world where technology data and patient expectations are evolving rapidly To tr...

Trump Tariff Tyranny and Pharma Preparedness

On August President Trump announced the imposition of an additional per cent tariff on India specifically linked to its continued purchase of Russian oil This move has effectively increased the overall tariff burden on Indian exports to the United States to nearly per cent The sectors most affect...

Peptide-Drug Conjugates in Precision Oncology

Engineering next-generation targeted therapies

Cancer therapies have evolved from broadly cytotoxic agents to increasingly refined and targeted treatments Amidst this transformation peptidedrug conjugates PDCs have emerged as a promising class of bioconjugates that offer the precision of targeted delivery combined with the potency of cytotoxic d...

Generative AI and the New Era of Personalized Medicine

For decades drug discovery has been one of sciences most laborious and expensive pursuits Despite extraordinary progress in chemistry and biology most candidate molecules that enter clinical trials fail to become approved medicines The process is slow costly and heavily dependent on luck and trialan...

Precision medicine for Alzheimer’s Disease

Emerging Paradigm in Genomics, Biomarkers & AI tools

Alzheimers disease a common cause of dementia is characterised by deposition of senile plaques and neurofibrillary tangles These protein deposits are inherent key features of AD distinguishing from other types of dementia AD also notably marks with neuroinflammation oxidative stress

Nanotechnology based Drug Delivery for Infectious Diseases

Infectious diseases continue to pose a serious threat to global health particularly in the face of rising antimicrobial resistance AMR emerging viral outbreaks COVID and neglected tropical diseases with an estimated million fatalities linked to bacterial AMR in The WHO research agenda for antimicr...

The Growing Role of Biocatalysis in Industrial Synthesis

Since the late th century chemical catalysis has been a cornerstone of organic synthesis and pharmaceutical manufacturing driving the development and mass production of key therapeutic molecules across multiple disease areas Despite its broad adoption and long history traditional organic synthesis t...

Natural Polymers and Fibers in Drug Delivery

Advancements in drug delivery have become increasingly critical due to the growing demand for more effective targeted and personalized therapies Modern drug delivery systems are designed not only to enhance the bioavailability and release of drugs but also to optimise pharmacokinetic parameters such...

Green Synthesis of Metallic Nanoparticles

A Sustainable Leap in Pharmaceutical Nanotechnology

Nanotechnology has transformed the pharmaceutical landscape offering revolutionary solutions in drug delivery diagnostics and therapeutics However traditional methods of synthesizing nanoparticles often rely on hazardous chemicals consume high energy and generate toxic byproducts As the industry lea...

Unlocking New Avenues in Cancer Therapy by Targeting Ubiquitin-Specific Proteases

The ubiquitinproteasome system UPS is a crucial mechanism that helps maintain balance within our cells by breaking down damaged or excess proteins Central to this process is ubiquitination where a small protein called ubiquitin made up of amino acids attaches to target proteins thus influencing the...

Impact Assessment of US Tariff Threat on Indian Healthcare Export

The ongoing tariff fusillades and retorts by the economies like China have precipitated several conundrums and made the trade future nebulous The flat per cent of reciprocal tariff across the sectors include the medical device also The pharmaceutical sector has been kept exempted The current tariff...